Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic version of qsymia?Berdazimer sodium synthesis patent?Super refined castor oil fulvestrant or other drug examples?Can you provide a timeline for apotex's ruxolitinib approval and launch in the us?Baricitinib phosphate salt patent?
See the DrugPatentWatch profile for linzess
Linzess (linaclotide) was approved by the FDA on August 28, 2012. 1
Linzess is used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C). 1
Other Questions About Linzess :